Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3244.5
(0.37%)
INR 3244.5
(0.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 16.04 Billion INR | -37.08% |
| 2022 | 25.49 Billion INR | 18.01% |
| 2021 | 21.6 Billion INR | -27.11% |
| 2020 | 29.63 Billion INR | -10.31% |
| 2019 | 33.03 Billion INR | -15.57% |
| 2018 | 39.12 Billion INR | -4.83% |
| 2017 | 41.11 Billion INR | 83.48% |
| 2016 | 22.4 Billion INR | 21.12% |
| 2015 | 18.5 Billion INR | -14.86% |
| 2014 | 21.72 Billion INR | 191.87% |
| 2013 | 7.44 Billion INR | 63.78% |
| 2012 | 4.54 Billion INR | 41.14% |
| 2011 | 3.22 Billion INR | 9.9% |
| 2010 | 2.93 Billion INR | -43.9% |
| 2009 | 5.22 Billion INR | 8.25% |
| 2008 | 4.82 Billion INR | 34.14% |
| 2007 | 3.59 Billion INR | 20.36% |
| 2006 | 2.98 Billion INR | 12.62% |
| 2005 | 2.65 Billion INR | 24.98% |
| 2004 | 2.12 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 14.14 Billion INR | 0.0% |
| 2023 FY | 16.04 Billion INR | -37.08% |
| 2023 Q2 | 21.61 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 16.04 Billion INR | 0.0% |
| 2022 Q2 | 24.53 Billion INR | 0.0% |
| 2022 FY | 25.49 Billion INR | 18.01% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 25.49 Billion INR | 0.0% |
| 2021 FY | 21.6 Billion INR | -27.11% |
| 2021 Q2 | 24.23 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 21.6 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 36.57 Billion INR | 0.0% |
| 2020 FY | 29.63 Billion INR | -10.31% |
| 2020 Q4 | 29.63 Billion INR | 0.0% |
| 2019 Q4 | 33.03 Billion INR | 0.0% |
| 2019 FY | 33.03 Billion INR | -15.57% |
| 2019 Q2 | 39.57 Billion INR | 0.0% |
| 2018 Q4 | 39.12 Billion INR | 0.0% |
| 2018 Q2 | 40.16 Billion INR | 0.0% |
| 2018 FY | 39.12 Billion INR | -4.83% |
| 2017 FY | 41.11 Billion INR | 83.48% |
| 2017 Q4 | 41.11 Billion INR | 0.0% |
| 2017 Q2 | 20.99 Billion INR | 0.0% |
| 2016 Q4 | 22.4 Billion INR | 0.0% |
| 2016 FY | 22.4 Billion INR | 21.12% |
| 2016 Q2 | 20.64 Billion INR | 0.0% |
| 2015 Q4 | 18.5 Billion INR | 0.0% |
| 2015 Q2 | 22.74 Billion INR | 0.0% |
| 2015 FY | 18.5 Billion INR | -14.86% |
| 2014 Q2 | 21.05 Billion INR | 0.0% |
| 2014 Q4 | 21.72 Billion INR | 0.0% |
| 2014 FY | 21.72 Billion INR | 191.87% |
| 2013 Q2 | 4.19 Billion INR | 0.0% |
| 2013 Q4 | 7.44 Billion INR | 0.0% |
| 2013 FY | 7.44 Billion INR | 63.78% |
| 2012 Q4 | 4.54 Billion INR | 0.0% |
| 2012 FY | 4.54 Billion INR | 41.14% |
| 2011 Q4 | 3.22 Billion INR | 0.0% |
| 2011 FY | 3.22 Billion INR | 9.9% |
| 2010 FY | 2.93 Billion INR | -43.9% |
| 2009 FY | 5.22 Billion INR | 8.25% |
| 2008 FY | 4.82 Billion INR | 34.14% |
| 2007 FY | 3.59 Billion INR | 20.36% |
| 2006 FY | 2.98 Billion INR | 12.62% |
| 2005 FY | 2.65 Billion INR | 24.98% |
| 2004 FY | 2.12 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -2450.891% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 24.868% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -10766.472% |
| Granules India Limited | 689.71 Million INR | -2225.615% |
| Indoco Remedies Limited | 3.51 Billion INR | -356.032% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -6719.728% |
| Alkem Laboratories Limited | 400 Million INR | -3910.0% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -449829.874% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -57523.222% |
| Bajaj HealthCare Limited | 650.34 Million INR | -2366.383% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -4406.605% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -167.78% |
| Eris Lifesciences Limited | 6.54 Billion INR | -145.07% |
| FDC Limited | 2.46 Million INR | -650346.067% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -957.413% |
| Gufic Biosciences Limited | 1.53 Billion INR | -941.808% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -14269.412% |
| Ipca Laboratories Limited | 5.8 Billion INR | -176.356% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -21125.354% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -774.114% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | -86.427% |
| Lupin Limited | 1.55 Billion INR | -932.973% |
| Mankind Pharma Limited | 248.67 Million INR | -6350.134% |
| Medicamen Biotech Limited | 12.55 Million INR | -127657.865% |
| Medico Remedies Limited | 8.67 Million INR | -184863.1% |
| Megasoft Limited | 1.35 Billion INR | -1081.959% |
| NATCO Pharma Limited | 53 Million INR | -30164.151% |
| Piramal Pharma Limited | 24.83 Billion INR | 35.42% |
| RPG Life Sciences Limited | -30.3 Million INR | 53037.294% |
| Sigachi Industries Limited | 265.79 Million INR | -5934.658% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -120501.504% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -7453.354% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 1315932.65% |
| Unichem Laboratories Limited | 382.22 Million INR | -4096.525% |
| Wanbury Limited | 820 Million INR | -1856.098% |
| Windlas Biotech Limited | 20.18 Million INR | -79384.638% |
| ZIM Laboratories Limited | 356 Million INR | -4405.542% |
| Zydus Lifesciences Limited | 251 Million INR | -6290.438% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -14946.904% |
| Divi's Laboratories Limited | 20 Million INR | -80100.0% |
| Hester Biosciences Limited | 1.81 Billion INR | -782.419% |
| Procter & Gamble Health Limited | 68.8 Million INR | -23213.953% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -114733.906% |
| Bal Pharma Limited | 363.82 Million INR | -4308.725% |
| Strides Pharma Science Limited | 6.71 Billion INR | -138.869% |
| Venus Remedies Limited | 386.8 Million INR | -4046.846% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -4009900.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -1043.194% |
| Shilpa Medicare Limited | 5.6 Billion INR | -186.347% |
| Aarti Drugs Limited | 2.75 Billion INR | -482.574% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | -58.89% |
| Valiant Laboratories Limited | 746.63 Million INR | -2048.32% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -6685.11% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -1415.638% |
| Themis Medicare Limited | 267.74 Million INR | -5890.887% |
| Hikal Limited | 4.22 Billion INR | -279.331% |
| Sequent Scientific Limited | 1.42 Billion INR | -1023.887% |
| Novartis India Limited | 50.7 Million INR | -31537.081% |
| Wockhardt Limited | 8.91 Billion INR | -80.022% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 49.354% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -3470.745% |
| Morepen Laboratories Limited | 33.64 Million INR | -47581.332% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -11911.292% |